News | September 03, 2023
BioNTech to lead $2 billion mRNA-based oncology therapy market despite challenges, says GlobalData
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Aims to build the largest connected healthcare ecosystem in India
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
